To determine whether adjuvant chemoradiation (CRT) with weekly cisplatin improves recurrence-free survival (RFS) compared with radiation (RT) in pathologically proven intermediate risk early-stage cervical cancer following radical hysterectomy and lymphadenectomy.
Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008☆
Annals of Oncology | | S.Y. Ryu, W. Deng, K. Albuquerque, W.-J. Koh, J. Mayadev, A. Heugel, B.-J. Kim, D.-Y. Kim, C.-H. Cho, J.-W. Kim, J.H. No, R.S. Mannel, K. Miller, D. Fabian, D.M. Chase, K.M. Gil, W. Small, W. Rodgers, C.A. Leath, B.J. Monk
Topics: blood-cancer, cervical-cancer, chemotherapy, clinical-trials